Collegium Pharmaceutical Inc Cash Flow Reinvestment Rate
Collegium Pharmaceutical Inc cash flow reinvestment rate. Collegium Pharmaceutical Inc (COLL) has a Cash Flow Reinvestment Rate of 0.40x as of September 2025, reinvesting $31.06 Million (capex $188.00K plus investments $-30.87 Million) from operating cash flow of $78.44 Million. Explore Collegium Pharmaceutical Inc cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Collegium Pharmaceutical Inc (2018–2024)
Cash flow reinvestment rate of Collegium Pharmaceutical Inc from 2018 to 2024. Historical reinvestment intensity for Collegium Pharmaceutical Inc across 7 annual periods. Explore Collegium Pharmaceutical Inc (COLL) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Collegium Pharmaceutical Inc Cash Flow Reinvestment Rate by Year (2018–2024)
Collegium Pharmaceutical Inc cash flow reinvestment rate by year from 2018 to 2024. Year-by-year capital reinvestment analysis for Collegium Pharmaceutical Inc. For the full cash flow conversion analysis, see Collegium Pharmaceutical Inc (COLL) cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.41x | $289.41 Million | $204.98 Million | $1.65 Million | ▲ +723.3% |
| 2023 | 0.17x | $47.12 Million | $274.75 Million | $461.00K | ▼ -96.3% |
| 2022 | 4.63x | $575.31 Million | $124.23 Million | $1.62 Million | ▲ +12234.8% |
| 2021 | 0.04x | $3.89 Million | $103.56 Million | $1.94 Million | ▼ -99.5% |
| 2020 | 7.96x | $747.54 Million | $93.94 Million | $373.77 Million | ▲ +1617.0% |
| 2019 | 0.46x | $12.88 Million | $27.78 Million | $6.44 Million | ▲ +61.2% |
| 2018 | 0.29x | $48.71 Million | $169.39 Million | $24.35 Million | — |